Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 8/2006

01-08-2006 | Research Articles

Impact of neoadjuvant hormonal therapy on dose-volume histograms in patients with localized prostate cancer under radical radiation therapy

Authors: Pilar M. Samper, Concepción López Carrizosa, Ana Pérez Casas, Carmen Vallejo, M, Carmen Rubio Rodríguez, Consuelo Pérez Vara, Miguel Melchor Iñiguez

Published in: Clinical and Translational Oncology | Issue 8/2006

Login to get access
Metadata
Title
Impact of neoadjuvant hormonal therapy on dose-volume histograms in patients with localized prostate cancer under radical radiation therapy
Authors
Pilar M. Samper
Concepción López Carrizosa
Ana Pérez Casas
Carmen Vallejo
M
Carmen Rubio Rodríguez
Consuelo Pérez Vara
Miguel Melchor Iñiguez
Publication date
01-08-2006
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 8/2006
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-006-0066-0

Other articles of this Issue 8/2006

Clinical and Translational Oncology 8/2006 Go to the issue

Case Reports

Cushing's paraneoplastic syndrome as first manifestation of an adenocarcinoma of unknown origin

Review

New target-based agents involve new clinical trial designs

Editorial

Surgical management of peritoneal carcinomatosis: from clinical research to standard of care

Educational Series

Therapeutic opportunities and targets in childhood leukemia

Research Articles

Epidemiological pattern and time trends in testicular germ-cell tumors: a single institution 20-year experience

Educational Series

Contributions of advanced proteomics technologies to cancer diagnosis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits